RPA1 and cancer: RPA has been shown to be over-expressed in several cancers including lung, ovarian, breast, colon, bladder, gastric, hepatic, and esophageal and these solid tumors may rely on RPA to mitigate the replication stress associated with these cancers (135, 139, 140).